statistical analysis of pAkt 473 /Akt tot (total Akt) over the unchallenged control (from left to right n= 3, 7, 11 independent experiments respectively). Results represent mean±s.e.m. , *P<0.05, **P<0.01, ***P<0.001 determined using one-way ANOVA followed by Bonferroni post-hoc experiments respectively). Results represent mean±s.e.m. , * P<0.05, **P<0.01, ***P<0.001 determined using one-way ANOVA followed by Bonferroni post-hoc test. (from left to right n= 10, 7, 6, 7 independent experiments respectively). Results represent mean±s.e.m. , *P<0.05 determined using one-way ANOVA followed by Bonferroni post-hoc test.
Supplementary
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Supplementary Figure 8: Analysis of Myeloperoxidase (MPO)
(A) and eosinophil peroxidase (EPO) (B) in mice treated with CL27c alone or combined with dexamethasone (Dexa) (from left to right groups, MPO n= 5, 7, 7, 7, 5, EPO n= 5, 7, 7, 7, 5 independent experiments respectively). Results represent mean±s.e.m. , *P<0.05, **P<0.01, ***P<0.001 determined using one-way ANOVA followed by Bonferroni post-hoc test. 
Supplementary Table 1. In vitro plasma half-life (t1/2), (mouse plasma).
Values are the mean of at least triplicate determination in a single experiment.
CL27c
CL27e cultured and utilized at passages 2-3 and 3-6, respectively, to limit passage dependent bias. For experiments, medium was replaced with serum free medium, for a 1 hour-long starvation.
Kinome profiling assay
The enzyme assay panel (Nanosyn Biology, Inc., Santa Clara, CA, USA) employs microfluidics capillary electrophoresis technology to measure the change in electrophoretic mobility of the substrate upon phosphorylation. CL27c active metabolite, CL27e, was plated at 100x of the screening concentrations (0.02 or 0.2 µM) to be tested in a single point screening against 250 kinases. The buffer components (Magnesium Buffer [100 mM HEPES pH7.5; 0.01% Triton X-100; 0.1% BSA; 5 mM MgCl2; 1 mM DTT; 10 µM Sodium Orthovanadate; 10 µM BetaGlycerophosphate]; Manganese Buffer [100 mM HEPES pH7.5; 0.01% Triton X-100; 0.1% BSA; 5 or 10 mM MnCl2; 1 mM DTT; 10 µM Sodium Orthovanadate; 10 µM BetaGlycerophosphate]; Manganese/Magnesium Buffer [100 mM HEPES pH7.5; 0.01% Triton X-100; 0.1% BSA; 5mM MgCl2; 1 mM MnCl2; 1 mM DTT; 20 µM Sodium Orthovanadate; 20 µM Beta-Glycerophosphate]) and assay conditions were adjusted based on the specific assay (Table S4) . Briefly, enzyme buffer (5 µl/well) was added with ATP (at apparent Km for each kinase, Table S4 ) to the 384-well assay plate. Then, the compound (100 nl) was transferred to the assay plate (Labcyte Echo 550, San Jose, CA, USA), followed by the substrate buffer (5 µl/well).
The reaction mixture was incubated at 25oC according to the assay specific incubation time. For
30
Caliper based assay, the reaction was terminated by addition of EDTA buffer. Substrate and product were separated and quantified electrophoretically using the microfluidic-based and the assay plate was read on Caliper LabChip 3000 Drug Discovery System from Caliper Life Sciences (Walthan, MA, USA). ADP Glo was another method of detection used for some kinase assays where data was obtained by quantifying the intensity of luminescence. For ADP Glo based assay, the reaction was terminated by applying the Promega ADP Glo Kinase Assay kit and the assay plate was read on a LJL Biosystems Analyst HT.
Measurement of AKT phosphorylation and cell survival of Human Lung Fibroblasts
Control and IPF HLF (described above) were seeded in a 96-well tissue culture plates at 1 x 10 5 cells/well (Falcon, Germany) and starved in serum-free medium for 2 hours. Protein extraction was performed 10 minutes after serum stimulation. AKT phosphorylation was measured by western blot, as described in the "Western blot analysis" in the Methods section. 
Measurement of Mucus Production
Lungs were removed and fixed in Milloning buffer solution (pH 7.4) with 4% paraformaldehyde.
For analysis of inflammation score around the bronchial region, the lung sections were stained with hematoxylin and eosin (H&E). Mucus production was analyzed from tissue sections stained with Harris hematoxylin stain and a combination of Periodic acid-Schiff (PAS) stain.
Photomicrographs of airways obtained at 400 × magnification were analyzed using the software were expressed as extracellular matrix deposition area (pixels).
Microsomial stability
All tests for the microsomial stability of CL27c were conducted by the Istituto di Ricerche Biomediche (RBM) SpA -Merck Serono, Ivrea, Italy.
PBMCs measurement of Akt phosphorylation
PBMCs in RPMI medium were seeded in a 96-well tissue culture plates at 1 x 10 5 cells/well (Falcon). PBMCs were activated with vehicle (PBS) or anti-CD3 (1 µg/mL) plus soluble anti-CD28 (1 µg/mL) mAbs (BD Pharmingen, San Jose, CA, USA). Then, cells pretreated with different doses of CL27c were incubated at 37°C and 5% CO 2 for 10 minutes.
Akt phosphorylation was measured by western blot as described in the "Western blot analysis" in the Methods section. Pharmacokinetic studies.
